A New Treatment Plan May Reverse Cognitive Decline in People at Risk for Alzheimer’s


Worrying about your cognitive function is exhausting. You might be asking yourself questions like:
In recent years, effective treatments for cognitive decline have been evading researchers and doctors. With the rates of Alzheimer’s disease increasing at an alarming rate, it is essential that an effective solution is developed.
No drug therapies have been successful at treating cognitive decline and Alzheimer’s disease.
Thankfully, a recent study made an incredible breakthrough.
A clinical trial found a method to improve memory and cognitive function in people at risk for Alzheimer’s Disease.
And it is not a drug.
Heather Sandison, ND, and her team found that complex, multimodal, individualized therapy was an effective way to stop and reverse cognitive decline. According to the research abstract, “No monotherapy has substantially altered disease progression, suggesting the disease is multifactorial and may require a multimodal therapeutic approach.”
Monotherapy refers to using a single medication or therapy to treat a health condition.
Examples of monotherapies include:
Monotherapies do work for certain conditions, but not for Alzheimer’s disease. Multimodal therapeutic approaches appear to be needed.
The therapeutic approach used by Dr. Sandison and her team is a multimodal therapy.
Multimodal therapy refers to using more than one therapeutic technique to treat a health condition.
Examples of multimodal therapies include:
From the results of Dr. Sandison’s study, a multimodal therapeutic approach was able to reverse cognitive decline. So, what does Dr. Sandison‘s multimodal therapy include? And why does it work?

Dr. Sandison and her team theorized that a single treatment type may not be enough to reverse cognitive decline. That is why the therapy in this study was individualized for each participant.
The interventional therapy included the following aspects:
Modifying each of these based on physical ability and treatment tolerance allowed each participant to receive a personalized plan.
The individualized therapy caused incredible results. Over 70% of the participants improved their cognitive function.
And it only took 6 months.

To test mental functioning, Dr. Sandison’s team performed the Cambridge Brain Sciences assessments and the Montreal Cognitive Assessment. These are both gold standard tests for determining a person’s level of cognitive function. Participants (n= 34) were recruited from the San Diego, CA area.
Participants took the tests before the start of the study and again at 6 months of study participation.
After 6 months of individualized therapy, the test results were astounding. Dr. Sandison and her team found improvements in:
These improvements were statistically significant, and the mean change in overall cognition increased by 5.2%.
These populations are expected to see a continual decline, but this therapy shows that people experiencing cognitive decline can reverse it.
So, what is next?
The success of this study sets the stage for larger, clinical trials. If these findings are replicated on a bigger scale, they could revolutionize the treatment approach for cognitive decline.
If the next clinical trials are successful, Dr. Sandison and her team may have found a way to give millions of people a chance of a better life.
In the face of decades of limited success in the realm of cognitive decline therapeutics, this study lights a beacon of hope. This unique study demonstrates the importance of taking a holistic, individualized approach to treating cognitive dysfunction.
Dr. Heather Sandison, ND – Peptides and Neurohacking
The Role of Toxins in Dementia
Welcome To Reverse Alzheimer’s 3.0 Summit
Sandison, H., Callan, N. G. L., Rao, R. V., Phipps, J., & Bradley, R. (2023). Observed Improvement in Cognition During a Personalized Lifestyle Intervention in People with Cognitive Decline. Journal of Alzheimer’s disease : JAD, 94(3), 993–1004. Read it here.
Get weekly expert content delivered to your inbox.